Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
ACS Synth Biol ; 10(9): 2396-2408, 2021 09 17.
Artigo em Inglês | MEDLINE | ID: mdl-34399052

RESUMO

Ubiquibodies (uAbs) are a customizable proteome editing technology that utilizes E3 ubiquitin ligases genetically fused to synthetic binding proteins to steer otherwise stable proteins of interest (POIs) to the 26S proteasome for degradation. The ability of engineered uAbs to accelerate the turnover of exogenous or endogenous POIs in a post-translational manner offers a simple yet robust tool for dissecting diverse functional properties of cellular proteins as well as for expanding the druggable proteome to include tumorigenic protein families that have yet-to-be successfully drugged by conventional inhibitors. Here, we describe the engineering of uAbs composed of human carboxyl-terminus of Hsc70-interacting protein (CHIP), a highly modular human E3 ubiquitin ligase, tethered to differently designed ankyrin repeat proteins (DARPins) that bind to nonphosphorylated (inactive) and/or doubly phosphorylated (active) forms of extracellular signal-regulated kinase 1 and 2 (ERK1/2). Two of the resulting uAbs were found to be global ERK degraders, pan-specifically capturing all endogenous ERK1/2 protein forms and redirecting them to the proteasome for degradation in different cell lines, including MCF7 breast cancer cells. Taken together, these results demonstrate how the substrate specificity of an E3 ubiquitin ligase can be reprogrammed to generate designer uAbs against difficult-to-drug targets, enabling a modular platform for remodeling the mammalian proteome.


Assuntos
Proteína Quinase 1 Ativada por Mitógeno/metabolismo , Proteína Quinase 3 Ativada por Mitógeno/metabolismo , Ubiquitina-Proteína Ligases/metabolismo , Linhagem Celular , Proteínas de Repetição de Anquirina Projetadas/química , Proteínas de Repetição de Anquirina Projetadas/metabolismo , Humanos , Fosforilação , Proteólise , Especificidade por Substrato , Ubiquitina/metabolismo , Ubiquitina-Proteína Ligases/química , Ubiquitina-Proteína Ligases/genética , Ubiquitinação
2.
PLoS One ; 15(7): e0236550, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32730290

RESUMO

The idea that biodiversity is necessary in order for ecosystems to function properly has long been used as a basic argument for the conservation of species, and has led to an abundance of research exploring the relationships between species richness and ecosystem function. Here we present a meta-analysis of global ecosystems using the Bray-Curtis index to explore more complex changes in the species composition of natural ecosystems, and their relationship with ecosystem functions. By using data recorded, firstly in reference sites and secondly in recovering sites, captured in restoration ecology studies, we pose the following questions: Firstly, how much variation is there in species composition and in ecosystem function in an intact ecosystem? Secondly, once an ecosystem has become degraded, is there a general relationship between its recovery in species composition and its recovery in ecosystem function? Thirdly, is this relationship the same for all types of ecosystem functions? Data from 21 studies yielded 478 comparisons of mean values for ecosystems. On Average, sites within the same intact natural ecosystems shared only a 48% similarity in species composition but were 69% similar in ecosystem functioning. In recovering ecosystems the relationship between species composition and ecosystem function was weak and saturating (directly accounting for only 2% of the variation). Only two of the six types of ecosystem function examined, biomass and biotic structure, showed a significant relationship with species composition, and the three types that measured soil functions showed no significant relationship. To date, most biodiversity-ecosystem function (BEF) research has been conducted in simplified ecosystems using the simple species richness metric. This study encourages a broader examination of the drivers of ecosystem functions under realistic scenarios of biodiversity change, and highlights the need to properly account for the extensive natural variation.


Assuntos
Ecossistema , Biodiversidade , Biomassa , Bases de Dados Factuais , Recuperação e Remediação Ambiental , Solo/química
3.
Jt Comm J Qual Patient Saf ; 46(1): 3-10, 2020 01.
Artigo em Inglês | MEDLINE | ID: mdl-31786147

RESUMO

BACKGROUND: Clinical decision support (CDS) alerting tools can identify and reduce medication errors. However, they are typically rule-based and can identify only the errors previously programmed into their alerting logic. Machine learning holds promise for improving medication error detection and reducing costs associated with adverse events. This study evaluates the ability of a machine learning system (MedAware) to generate clinically valid alerts and estimates the cost savings associated with potentially prevented adverse events. METHODS: Alerts were generated retrospectively by the MedAware system on outpatient data from two academic medical centers between 2009 and 2013. MedAware alerts were compared to alerts in an existing CDS system. A random sample of 300 alerts was selected for medical record review. Frequency and severity of potential outcomes of alerted medication errors of medium and high clinical value were estimated, along with associated health care costs of these potentially prevented adverse events. RESULTS: A total of 10,668 alerts were generated. Overall, 68.2% of MedAware alerts would not have been generated by the existing CDS system. Ninety-two percent of a random sample of the chart-reviewed alerts were accurate based on structured data available in the record, and 79.7% were clinically valid. Estimated cost of adverse events potentially prevented in an outpatient setting was more than $60 per drug alert and $1.3 million when extrapolating study findings to the full patient population. CONCLUSION: A machine learning system identified clinically valid medication error alerts that might otherwise be missed with existing CDS systems. Estimates show potential for cost savings associated with potentially prevented adverse events.


Assuntos
Sistemas de Apoio a Decisões Clínicas , Sistemas de Registro de Ordens Médicas , Preparações Farmacêuticas , Redução de Custos , Humanos , Aprendizado de Máquina , Erros de Medicação/prevenção & controle , Estudos Retrospectivos
4.
Am J Health Syst Pharm ; 76(13): 970-979, 2019 Jun 18.
Artigo em Inglês | MEDLINE | ID: mdl-31361884

RESUMO

PURPOSE: To examine the extent to which outpatient clinicians currently document drug indications in prescription instructions. METHODS: Free-text sigs were extracted from all outpatient prescriptions generated by the computerized prescriber order entry system of a major academic institution during a 5-year period. Natural language processing was used to identify drug indications. The data set was analyzed to determine the rates at which prescribers included indications. It was stratified by provider specialty, drug class, and specific medications, to determine how often these indications were in prescriptions for as-needed (PRN) versus non-PRN medications. RESULTS: During the study period, 4,356,086 prescriptions were ordered. Indications were included in 322,961 orders (7.41%). From these orders, 249,262 indications (77.18%) were written for PRN orders. Although internal medicine prescribers generated the highest number of medication orders, they included indications in only 6.26% of their prescriptions, whereas orthopedic surgery providers had the highest rate of documenting indications (33.41%). Pain was the most common indication, accounting for 30.35% of all documented indications. The drug class with the highest number of sigs-containing indications was narcotic analgesics. Non-PRN chronic medication prescriptions rarely included the indication. CONCLUSION: Prescribers rarely included drug indications in electronic free-text prescription instructions, and, when they did, it was mostly for PRN uses such as pain.


Assuntos
Assistência Ambulatorial/estatística & dados numéricos , Prescrições de Medicamentos/estatística & dados numéricos , Sistemas de Registro de Ordens Médicas/estatística & dados numéricos , Assistência Ambulatorial/normas , Conjuntos de Dados como Assunto , Prescrições de Medicamentos/normas , Humanos , Sistemas de Registro de Ordens Médicas/normas , Erros de Medicação/prevenção & controle , Processamento de Linguagem Natural
5.
JAMA Netw Open ; 2(3): e191514, 2019 03 01.
Artigo em Inglês | MEDLINE | ID: mdl-30924903

RESUMO

Importance: The indication (reason for use) for a medication is rarely included on prescriptions despite repeated recommendations to do so. One barrier has been the way existing electronic prescribing systems have been designed. Objective: To evaluate, in comparison with the prescribing modules of 2 leading electronic health record prescribing systems, the efficiency, error rate, and satisfaction with a new computerized provider order entry prototype for the outpatient setting that allows clinicians to initiate prescribing using the indication. Design, Setting, and Participants: This quality improvement study used usability tests requiring internal medicine physicians, residents, and physician assistants to enter prescriptions electronically, including indication, for 8 clinical scenarios. The tool order assignments were randomized and prescribers were asked to use the prototype for 4 of the scenarios and their usual system for the other 4. Time on task, number of clicks, and order details were captured. User satisfaction was measured using posttask ratings and a validated system usability scale. The study participants practiced in 2 health systems' outpatient practices. Usability tests were conducted between April and October of 2017. Main Outcomes and Measures: Usability (efficiency, error rate, and satisfaction) of indications-based computerized provider order entry prototype vs the electronic prescribing interface of 2 electronic health record vendors. Results: Thirty-two participants (17 attending physicians, 13 residents, and 2 physician assistants) used the prototype to complete 256 usability test scenarios. The mean (SD) time on task was 1.78 (1.17) minutes. For the 20 participants who used vendor 1's system, it took a mean (SD) of 3.37 (1.90) minutes to complete a prescription, and for the 12 participants using vendor 2's system, it took a mean (SD) of 2.93 (1.52) minutes. Across all scenarios, when comparing number of clicks, for those participants using the prototype and vendor 1, there was a statistically significant difference from the mean (SD) number of clicks needed (18.39 [12.62] vs 46.50 [27.29]; difference, 28.11; 95% CI, 21.47-34.75; P < .001). For those using the prototype and vendor 2, there was also a statistically significant difference in number of clicks (20.10 [11.52] vs 38.25 [19.77]; difference, 18.14; 95% CI, 11.59-24.70; P < .001). A blinded review of the order details revealed medication errors (eg, drug-allergy interactions) in 38 of 128 prescribing sessions using a vendor system vs 7 of 128 with the prototype. Conclusions and Relevance: Reengineering prescribing to start with the drug indication allowed indications to be captured in an easy and useful way, which may be associated with saved time and effort, reduced medication errors, and increased clinician satisfaction.


Assuntos
Prescrição Eletrônica , Modelos Teóricos , Melhoria de Qualidade , Assistência Ambulatorial , Pessoal de Saúde , Humanos , Sistemas de Registro de Ordens Médicas , Erros de Medicação/estatística & dados numéricos , Inovação Organizacional
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...